This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tremblay, C.
Right arrow Articles by Gaudreau, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tremblay, C.
Right arrow Articles by Gaudreau, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 1998, p. 1847-1849, Vol. 42, No. 7
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Antimicrobial Susceptibility Testing of 59 Strains of Campylobacter fetus subsp. fetus

Carole Tremblay and Christiane Gaudreau*

Département de Microbiologie Médicale et Infectiologie, Pavillon St-Luc, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada H2X 3J4

Received 7 October 1997/Returned for modification 15 January 1998/Accepted 15 April 1998

The susceptibilities of 59 Campylobacter fetus subsp. fetus isolates to eight antibiotics were studied by the agar dilution, E-test, and disk diffusion methods. None of the isolates were beta -lactamase producers. All were susceptible to ampicillin, gentamicin, imipenem, and meropenem as determined by the three methods, with MICs at which 90% of the isolates are inhibited (MIC90s) (determined by agar dilution) of 2, 1, <= 0.06, and 0.12 µg/ml, respectively. Twenty-seven percent of the isolates were resistant to tetracycline, with complete agreement between the agar dilution and disk diffusion results. The MIC90s determined by agar dilution were 2 µg/ml for erythromycin, 1 µg/ml for ciprofloxacin, and 8 µg/ml for cefotaxime.

* Corresponding author. Mailing address: Département de Microbiologie Médicale et Infectiologie, Pavillon St-Luc, CHUM, 1058 rue St-Denis, Montréal, Québec, Canada, H2X 3J4. Phone: (514) 281-2100. Fax: (514) 281-2443. E-mail: cgaudro{at}cam.org.

Antimicrobial Agents and Chemotherapy, July 1998, p. 1847-1849, Vol. 42, No. 7
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gibreel, A., Kos, V. N., Keelan, M., Trieber, C. A., Levesque, S., Michaud, S., Taylor, D. E. (2005). Macrolide Resistance in Campylobacter jejuni and Campylobacter coli: Molecular Mechanism and Stability of the Resistance Phenotype. Antimicrob. Agents Chemother. 49: 2753-2759 [Abstract] [Full Text]  
  • Tremblay, C., Gaudreau, C., Lorange, M. (2003). Epidemiology and Antimicrobial Susceptibilities of 111 Campylobacter fetus subsp. fetus Strains Isolated in Quebec, Canada, from 1983 to 2000. J. Clin. Microbiol. 41: 463-466 [Abstract] [Full Text]  
  • Heng, A.-E., De Champs, C., Souweine, B., Guy, L., Sirot, J., Deteix, P. (2002). Campylobacter fetus bacteraemia in a renal graft recipient. Nephrol Dial Transplant 17: 689-690 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»